Dr. Max Logan Gratrix, MD

Dr. Gratrix practices at Carson Dermatology in Carson City, Nevada.

Dr. Gratrix's NPI, 1275737710, was assigned on June 11, 2007. Dr. Gratrix graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2006. Dr. Gratrix's Maryland license number on file is D74403.

Dr. Gratrix's primary practice is Carson Dermatology, at 1100 S Carson St, Carson City, NV 89701. The practice phone is (775) 883-7811.

Dr. Gratrix's primary practice is Carson Dermatology in Carson City, Nevada. The medical group on file is Carson Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gratrix practices. Vendor and product names are available with a free account.

Dermatology is Dr. Gratrix's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gratrix is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gratrix's licenses on file in 3 states: Maryland, Nevada and Nebraska.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection, hives and itchy rashes among the conditions Dr. Gratrix treats.

CMS data shows 9,826 Medicare services from Dr. Gratrix across 36 procedure codes in 2024, for 2,318 Medicare patients. Medicare paid $571,495 for them. Every service was in an office.

CMS counts 2,318 Medicare patients who saw Dr. Gratrix in 2024. The largest group is 65 to 74, with 1,142 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gratrix's median patient age at 70, with 45% women.

In 2024, Dr. Gratrix wrote 986 Medicare Part D claims for 454 patients. 95% of them were for generic drugs. CMS names the drug for 848 of them, across 19 drugs with 11 or more claims each, at $122,865 in total drug cost. In 2023, CMS named 767 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gratrix for performance year 2024, reported as part of a group. Dr. Gratrix accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,989 procedures of removal of skin lesions by Dr. Gratrix, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Gratrix in 2017. 2017 was the busiest year, with 2. Dr. Gratrix has published most often in Am J Dermatopathol. Dr. Gratrix's most frequent co-authors are Aubrey Winn, MD, Joshua Bradley Kentosh, DO and Christina Ellen Brzezniak, DO.

CMS Open Payments shows 211 general payments to Dr. Gratrix from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $796.

Dr. Gratrix graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2006. Dr. Gratrix is a member of AOA, AAD and ASDS.

Dr. Gratrix is in network with 13 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.